Dysregulation of mTOR Signaling after Brain Ischemia

31Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

In this review, we provide recent data on the role of mTOR kinase in the brain under physiological conditions and after damage, with a particular focus on cerebral ischemia. We cover the upstream and downstream pathways that regulate the activation state of mTOR complexes. Furthermore, we summarize recent advances in our understanding of mTORC1 and mTORC2 status in ischemia–hypoxia at tissue and cellular levels and analyze the existing evidence related to two types of neural cells, namely glia and neurons. Finally, we discuss the potential use of mTORC1 and mTORC2 as therapeutic targets after stroke.

Cite

CITATION STYLE

APA

Villa-González, M., Martín-López, G., & Pérez-Álvarez, M. J. (2022, March 1). Dysregulation of mTOR Signaling after Brain Ischemia. International Journal of Molecular Sciences. MDPI. https://doi.org/10.3390/ijms23052814

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free